HST Global Inc. Shareholders Equity (Tangible)

Shareholders Equity (Tangible) of HSTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Shareholders Equity (Tangible) growth rates and interactive chart.


Highlights and Quick Summary

  • Shareholders Equity (Tangible) for the quarter ending June 29, 2020 was $-82.3 Thousand (a 114.88% increase compared to previous quarter)
  • Year-over-year quarterly Shareholders Equity (Tangible) decreased by -472.4%
  • Annual Shareholders Equity (Tangible) for 2019 was $-3.4 Thousand (a -99.9% decrease from previous year)
  • Annual Shareholders Equity (Tangible) for 2018 was $-3.37 Million (a 5.58% increase from previous year)
  • Annual Shareholders Equity (Tangible) for 2017 was $-3.19 Million (a 5.45% increase from previous year)
Visit stockrow.com/HSTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Shareholders Equity (Tangible) of HST Global Inc.

Most recent Shareholders Equity (Tangible)of HSTC including historical data for past 10 years.

Interactive Chart of Shareholders Equity (Tangible) of HST Global Inc.

HST Global Inc. Shareholders Equity (Tangible) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $-0.08 $-0.04
2019 $-0.0 $0.02 $-0.96 $-3.42 $-0.0
2018 $-3.37 $-3.33 $-3.28 $-3.24 $-3.37
2017 $-3.19 $-3.15 $-3.13 $-3.09 $-3.19
2016 $-3.03 $-2.98 $-2.94 $-2.9 $-3.03
2015 $-2.85 $-2.81 $-2.77 $-2.72 $-2.85
2014 $-2.66 $-2.61 $-2.57 $-2.52 $-2.66
2013 $-2.47 $-2.43 $-2.39 $-2.32 $-2.47
2012 $-2.28 $-2.19 $-2.1 $-1.99 $-2.28
2011 $-1.91 $-1.79 $-1.71 $-1.91
2010 $-1.84 $-1.68 $-1.53 $-1.32 $-1.85
2009 $-1.32 $-1.33

Business Profile of HST Global Inc.

Sector: Medical
Industry: Drugs
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.